Certis Oncology Announces Closing of $10 Million Series C Fundraising Round

Company Names John R. Tozzi as New Board Chairman

Read More

Certis Oncology Announces Presentation of Abstract at SNO Annual Meeting

Presentation to highlight predictive power of CertisAI™ approach to predict and test combination therapies for Glioblastoma Multiforme

Read More

Certis Oncology Solution's Self-Proclaimed Poster Boy: Jeffrey Alan Dinkin

It started with back pain.

Read More

Certis Oncology Named 'Overall Immunology Company of the Year' in 2023 Biotech Breakthrough Awards

San Diego, Calif. — November 9, 2023 – Certis Oncology Solutions (Certis), a translational science and precision oncology company, today announced it has been selected as "Overall Immunology Company of the Year" in the third annual BioTech...

Read More

Certis Oncology Solutions Announces Presentation of Abstract at Society for Immunotherapy of Cancer Annual Meeting

Presentation to highlight importance of study design in evaluating anti-tumor effects of immunotherapies in preclinical models

Read More

RAS Mutations in Cancer: Emerging Drug Development Strategies

For four decades, the causal link between RAS mutations in cancer – including the KRAS, HRAS, and NRAS genes – has been well-accepted. But for almost as long, oncology drug development has struggled to develop RAS inhibitors, and many had long...

Read More

For Immediate Release: ProPhase Labs Teams Up With Certis Oncology

Accelerating the Development of Novel Linebacker Compound

Read More

FOR IMMEDIATE RELEASE: SOTERIA Opens Cancer Research Study Leveraging Certis AI and Functional Assays

Dedicated Fund Now Open for Private Contributions

Read More

The Power of Predictive AI Models: Revolutionizing Cancer Research

Powerful computational tools, such as predictive artificial intelligence (AI) models, are reshaping preclinical research, leading to more optimized and streamlined drug discovery and drug development pipelines.1 In drug discovery, AI can be applied...

Read More

Functional Precision Oncology: Filling the Gap Left By Genomics-Based Approaches

Precision oncology (also known as personalized medicine in cancer treatment) is about matching an individual to the optimal therapy for their unique form of cancer. Many people associate personalized medicine with genetic testing. Genomic tumor...

Read More